Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014

Increasing resistance in Gram-negative bacilli, including Klebsiella spp., has reduced the utility of broad-spectrum cephalosporins. Avibactam, a novel non-β-lactam β-lactamase inhibitor, protects β-lactams from hydrolysis by Gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Hackel, Meredith, Kazmierczak, Krystyna M., Hoban, Daryl J., Biedenbach, Douglas J., Bouchillon, Samuel K., de Jonge, Boudewijn L. M., Stone, Gregory G.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2016
Matèries:
Epidemiology and Surveillance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4958227/
https://ncbi.nlm.nih.gov/pubmed/27216054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02841-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars